Task: Answer the multiple choice question.
Question: Which drug exhibits a -9.407% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCc1ccc(CN2CCN(Cc3cc(Br)ccc3O)CC2)cc1
b) C/C(=N\NC(=O)c1cc(-c2ccc(C)s2)nc2ccccc12)c1cccnc1
Answer: b. C/C(=N\NC(=O)c1cc(-c2ccc(C)s2)nc2ccccc12)c1cccnc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C/C(=N\NC(=O)c1cc(-c2ccc(C)s2)nc2ccccc12)c1cccnc1
C/C(=N\NC(=O)c1cc(-c2ccc(C)s2)nc2ccccc12)c1cccnc1
2-(5-methylthiophen-2-yl)-N-[(E)-1-pyridin-3-ylethylideneamino]quinoline-4-carboxamide